Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;201(6):1239-1244.
doi: 10.1111/bjh.18815. Epub 2023 Apr 14.

Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

Catia Simoes  1 , Sara Villar  1 , Beñat Ariceta  1 , Juan-José Garcés  1 , Leire Burgos  1 , Diego Alignani  1 , Sarai Sarvide  1 , David Martínez-Cuadrón  2 , Juan-Miguel Bergua  3 , Susana Vives  4 , Lorenzo Algarra  5 , Mar Tormo  6 , Pilar Martinez  7 , Josefina Serrano  8 , Pilar Herrera  9 , Fernando Ramos  10 , Olga Salamero  11 , Esperanza Lavilla  12 , Cristina Gil  13 , Jose-Luis Lopez-Lorenzo  14 , Maria-Belen Vidriales  15 , Carmen Chillon  15 , Jorge Labrador  16 , Jose-Francisco Falantes  17 , María-José Sayas  18 , Rosa Ayala  7 , Joaquin Martinez-Lopez  7 , Ana Alfonso Pierola  1 , Maria-Jose Calasanz  1   19 , Felipe Prosper  1 , Jesús F San-Miguel  1 , Miguel Á Sanz  2 , Bruno Paiva  1 , Pau Montesinos  2 ; PETHEMA cooperative study group
Affiliations

Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

Catia Simoes et al. Br J Haematol. 2023 Jun.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Short NJ, Zhou S, Fu C, Berry DA, Walter RB, Freeman SD, et al. Association of measurable residual disease with survival outcomes in patients with acute myeloid leukemia: a systematic review and meta-analysis. JAMA Oncol. 2020;6(12):1890-9. https://doi.org/10.1001/JAMAONCOL.2020.4600
    1. Kantarjian H, Ravandi F, O'Brien S, Cortes J, Faderl S, Garcia-Manero G, et al. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. Blood. 2010;116(22):4422-9. https://doi.org/10.1182/BLOOD-2010-03-276485
    1. Zeng AGX, Bansal S, Jin L, Mitchell A, Chen WC, Abbas HA, et al. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med. 2022;28:1212-23. https://doi.org/10.1038/s41591-022-01819-x
    1. DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and Venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020;383(7):617-29. https://doi.org/10.1056/NEJMOA2012971
    1. Swerdlow SH. WHO classification of tumours of haematopoietic and lymphoid tissues. Vol 22008. Lyon: International Agency for Research on Cancer; 2008.

Publication types

LinkOut - more resources